BCTXL BriaCell Therapeutics Corp. - Fundamental Analysis
BEARISH
Sign in to save
Save this symbol to a watchlist or track a position.
BCTXL Stock | Fundamental Analysis & Investment Insights
NASDAQ
N/A
N/A
Current Price
Live
$1.25
52W High
$1.32
52W Low
$1.2
At a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
Powered by advanced machine learning algorithms
Confidence Score
85%
Analysis Accuracy
The Advanced Deterministic Scorecard reveals a critically weak financial health profile with a Piotroski F-Score of just 2/9, indicating severe operational and financial distress. Despite a seemingly strong Current and Quick Ratio of 3.42, the company reports zero profitability across all margins and deeply negative ROE and ROA, signaling inefficient use of equity and assets. Valuation metrics are largely unavailable or non-existent, with no meaningful P/E, PEG, or EV/EBITDA data, while the stock shows no price momentum over multiple time horizons. The absence of Altman Z-Score and Graham Number, combined with stagnant performance and no analyst coverage, underscores extreme uncertainty and elevated risk.
Key Strengths
Current Ratio of 3.42 suggests short-term liquidity adequacy
Quick Ratio of 3.42 indicates ability to meet short-term obligations without inventory reliance
Price/Sales and EV/Revenue absence may imply limited revenue base rather than overvaluation
Insider Sentiment score of 40/100 shows some level of insider engagement
Stock price has remained stable near $1.25 with minimal volatility in recent periods
Key Risks
Piotroski F-Score of 2/9 indicates very weak financial health and high risk of underperformance
ROE of -444.07% and ROA of -161.64% reflect severe losses relative to equity and asset base
Zero gross, operating, and profit margins indicate no current path to profitability
No Altman Z-Score available, increasing uncertainty about bankruptcy risk
Lack of analyst coverage, target prices, and growth metrics signals low institutional interest and high information risk
Performance Snowflake
Multi-dimensional AI analysis across 5 key categories
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Historical Performance Trends
Long-term financial metrics and growth patterns
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability, Growth & Financial Health
Detailed profit margins, ROE, debt ratios, and liquidity metrics
Sector Comparison & Peer Analysis
Compare BCTXL against industry averages and similar companies
Insider Trading & Analyst Ratings
Track insider transactions and Wall Street analyst recommendations
Past News Coverage
Recent headlines mentioning BCTXL from our newsroom.
Newest → oldest
No matching news yet.